Da Di Sirrah Trump Limited

Company Description

Conroy PSP was first introduced to Hong Kong in 1985, since then, although not much effort was put in promotion, Conroy PSP still gained its popularity among cancer patients solely for its exclusive effectiveness. Moreover, Conroy PSP had also aroused the interest of several universities in Hong Kong to pursue further clinical studies and trails against its potency, and the result is positive and encouraging.It was not until 2003 that the Hong Kong SAR government commenced the long process of licensing every Chinese medicine sold in Hong Kong. With all the detailed documentation and laboratory test reports thoroughly and repeatedly examined and verified, Conroy PSP is finally awarded a Proprietary Chinese Medicine Transitional Registration Number HKP-03385 issued by the Chinese Medicine Council of Hong Kong. This number offers Conroy PSP a legitimate and solid ground for further development in the years to come and would greatly consolidate the faith of those who are doubtful but eagerly want a way out.